The pharmaceutical manufacturing sector faces increasing OT and ICS cybersecurity threats that can disrupt production, endanger workers, and expose sensitive data. As attackers target these facilities for financial gain or intellectual property theft, the industry must strengthen its defenses. OT environments controlling critical processes are particularly vulnerable due to legacy systems, limited visibility, and operational constraints that make patching difficult. Executives must understand these risks and invest in continuous improvement, including better asset visibility, stronger security practices, and coordinated incident response to maintain safety, productivity, and resilience.

Join for free to read